Related Experiment Video

Updated: Aug 10, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Antimicrobial treatment and prevention of meningitis

J O Klein1

  • 1Boston University School of Medicine, MA.

Pediatric Annals
|February 1, 1994
PubMed

Insights

The Haemophilus influenzae type b (Hib) vaccine significantly reduced meningitis cases. Physicians must maintain diagnostic and treatment skills for remaining meningitis cases, including aseptic meningitis.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • The conjugate polysaccharide *Haemophilus influenzae* type b (Hib) vaccine has dramatically decreased meningitis incidence.
  • While Hib meningitis is less common, physicians must remain proficient in diagnosing and treating all meningitis types.
  • Aseptic meningitis, often treatable with antimicrobials, requires diligent diagnostic efforts.

Purpose of the Study:

  • To emphasize the continued importance of meningitis diagnosis and treatment skills for physicians.
  • To highlight the need for aggressive diagnosis of aseptic meningitis.
  • To outline essential knowledge for appropriate pediatric meningitis management.

Main Methods:

  • Review of clinical management principles for bacterial and aseptic meningitis.
  • Emphasis on diagnostic procedures and timely antimicrobial administration.
  • Discussion of therapeutic adjustments based on pathogen identification and susceptibility testing.

Main Results:

  • Reduced incidence of Hib meningitis due to vaccination.
  • Continued prevalence of meningitis caused by *Streptococcus pneumoniae* and *Neisseria meningitidis*.
  • Importance of identifying treatable aseptic meningitis cases.

Conclusions:

  • Physicians need to maintain expertise in meningitis diagnosis and treatment despite reduced incidence of Hib meningitis.
  • Aggressive diagnostic approaches are crucial for aseptic meningitis.
  • Comprehensive knowledge of antimicrobial therapy, including dosing, monitoring, and prophylaxis, is essential for effective pediatric meningitis management.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...